Health Condition 1: I254- Coronary artery aneurysm and dissection
Conditions
Interventions
Intervention1: NA: NA
Control Intervention1: NA: NA
Sponsors
Dr Reddys Laboratories Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex aged>=18 years 2. Patients with a confirmed diagnosis (either by angiography or clinical findings) of first acute coronary event (STEMI [ST elevation myocardial infarction]/NSTEMI [non-ST elevation myocardial infarction]/ unstable angina) included in the study 3. Patients with minimum 12 months of data post statin therapy initiation and data extracted from their records in eCRF 4. Patients considered for initiation/ maintenance/modification of statin therapy before discharge from hospital
Exclusion criteria
Exclusion criteria: 1.Patients with a history of hospital admission for acute coronary syndrome in the past 12 months prior to the index event 2. Patients with known type 1 diabetes, history of malignancy, patients with active or suspected or with history of hepatic or stage 5 renal disease, history of uncontrolled hypothyroidism, alcohol, or drug abuse 3. Patients on hormone replacement therapy or oral contraceptives within 3 months of enrollment 4. Pregnant or breast-feeding women 5. Participation in any other interventional study in last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the study is to evaluate the change in prescribing patterns of statin therapy over one year period in adults presenting with first acute coronary eventTimepoint: The primary objective of the study is to evaluate the change in prescribing patterns of statin therapy over one year period in adults presenting with first acute coronary event | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To determine the distribution pattern of co-morbidities and risk factors like cardiovascular disease, hypertension, dyslipidemia, Diabetes, chronic kidney disease, obesity, family history of pre-mature CAD/FH, smoking among patients with first coronary events stratified by age, sexTimepoint: Percentage of patients with co-morbid conditions and risk factors including cardiovascular disease, hypertension, hyperlipidemia, Diabetes, chronic kidney disease, family history of CAD/FH, obesity and smoking among patients with first coronary events stratified by age, sex will be assessed at Baseline;To determine the adequacy of dyslipidemia treatment pattern in patients with ACS over one year periodTimepoint: Distribution pattern of statin/non-statin therapy in dyslipidemic patients with comorbidities will be assessed retrospectively from Baseline till upto 1 year. | — |
Countries
India
Contacts
Public ContactSucheta Pandit
Dr. Reddys Laboratories Ltd.
Outcome results
None listed